Search
Entecavir
go.drugbank.com/drugs/DB00442ApprovedInvestigationalIt was approved by the U.S. Food and Drug Administration (FDA) in March 2005. … and adefovir).
Categories: Nucleosides and Nucleotides, Nucleoside and Nucleotide Reverse Transcriptase InhibitorsProducts: BARACLUDE 1MG, ENTECAVIR AL 1MGBemiparin
go.drugbank.com/drugs/DB09258ApprovedInvestigationalWithdrawnBemiparin is an antithrombotic and belongs to the group of drugs known as the low molecular weight heparins (LMWH). … Interestingly, current research is underway for the potential benefit of bemiparin in the treatment of tumors and diabetic foot ulcers [L1468, A7866].
Categories: Heparin and similars, Blood and Blood Forming OrgansProducts: HIBOR® 3.500 UI., HIBOR® 10.000 UICyanocobalamin
go.drugbank.com/drugs/DB00115ApprovedInvestigationalNutraceuticalThe _cyano_ form, is the most widely used form in supplements and prescription drugs [A175255], [FDA label]. … This vitamin is produced naturally by bacteria [A175276], and is necessary for DNA synthesis and cellular energy production.
Mixtures: APIKOBAL 250MG/250MG/1MG FİLM KAPLI TABLET, 30 ADET, APIKOBAL 250MG/250MG/1MG FİLM KAPLI TABLET, 50 ADETCategories: Diet, Food, and Nutrition, Blood and Blood Forming OrgansClobazam
go.drugbank.com/drugs/DB00349ApprovedIllicitInvestigational[A256958] In 2005, clobazam also received approval from Health Canada as an add-on therapy for generalized tonic-clonic, myoclonic, and focal impaired awareness seizures.[A256978] … [A521,A522] In October 21, 2011, the FDA approved clobazam as an adjunctive treatment for seizures associated with Lennox-Gastaut syndrome in adults and children aged two years and older.
Categories: Benzodiazepines and benzodiazepine derivativesProducts: FRISIUM 10MG, Frisium Tab 10mgMethazolamide
go.drugbank.com/drugs/DB00703ApprovedA carbonic anhydrase inhibitor that is used as a diuretic and in the treatment of glaucoma.
Categories: Antiglaucoma Preparations and Miotics, Genito Urinary System and Sex HormonesProducts: Neptazane Tablets 25mg, Neptazane Tablets 25mg USPPomalidomide
go.drugbank.com/drugs/DB08910ApprovedInvestigationalPomalidomide, an analogue of thalidomide, is an immunomodulatory antineoplastic agent. FDA approved on February 8, 2013.
Categories: Antineoplastic and Immunomodulating AgentsProducts: POMALYST CAPSULE 1MG, Pomalyst Capsules 1mgPralatrexate
go.drugbank.com/drugs/DB06813ApprovedInvestigational[A246693] Pralatrexate is designed to have a higher affinity for the reduced folate carrier, a protein that is overexpressed in malignant cells and is upregulated by oncogenes. … [L37674] It is also being studied for other types of lymphoma and solid malignancy such as non-small-cell lung cancer, breast cancer, and bladder cancer.[A246678]
Categories: Antineoplastic and Immunomodulating AgentsSynonyms: (2S)-2-((4-((1RS)-1-((2,4-Diaminopteridin-6-yl)methyl)but-3-ynyl)benzoyl)amino)pentanedioic acidAntihemophilic factor (recombinant), PEGylated
go.drugbank.com/drugs/DB09329ApprovedInvestigationalPEGylation decreases factor VIII clearance and allowing for an increased duration of drug circulation in the plasma [L1529]. … Antihemophilic Factor (Recombinant), PEGylated, was approved by the FDA in December 2016 as the product _Adynovate_ [FDA label].
Categories: Amino Acids, Peptides, and ProteinsProducts: ADYNOVATE 3000 IU POWDER AND SOLVENT FOR SOLUTION FOR INJECTION, ADYNOVATE 250 IU POWDER AND SOLVENT FOR SOLUTION FOR INJECTIONTrastuzumab emtansine
go.drugbank.com/drugs/DB05773ApprovedInvestigationalFirst that trastuzumab emtansine and trastuzumab cannot be interchanged. … T-DM1 combines two strategies-- anti-HER2 activity and targeted intracellular delivery of the potent anti-microtubule agent, DM1 (a maytansine derivative)--to produce cell cycle arrest and apoptosis.
Categories: Amino Acids, Peptides, and Proteins, Antineoplastic and Immunomodulating AgentsProducts: KADCYLA POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/VIAL, KADCYLA POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 160MG/VIALCabazitaxel
go.drugbank.com/drugs/DB06772ApprovedInvestigationalCabazitaxel is a taxoid synthesized from 10-deacetylbaccatin III, a compound isolated from the yew tree. … It was first approved by the FDA on June 17, 2010.[A260421] It was also approved by the EMA on March 17, 2011 [L47381] and Health Canada on December 17, 2019.[L47376]
Categories: Antineoplastic and Immunomodulating AgentsProducts: JEVTANA 60mg CONCENTRATE AND SOLVENT FOR SOLUTION FOR INFUSION, Concentrate and Solvent for Solution for Infusion 60mg/1.5ml